Evidence map›Paper›PMID 40274975›Full record

ArticleScientific reports2025

Anti-inflammatory effects of

Max Temnik, Mariia Rudyk, Alexandr Balakin, Sergey Gurin, Taisa Dovbynchuk, Roman Byshovets, Nataliia Dzubenko, Ganna Tolstanova, Larysa Skivka

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Isotopically enrichedScientific reports · 2026
    Article
  2. ZnScientific reports · 2025
    Article
  3. Perturbations of Zinc Homeostasis and Onset of Neuropsychiatric Disorders.International journal of molecular sciences · 2025
    Review
  4. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Max TemnikPhysical Chemistry, Vector Vitale, North Miami Beach, USA.
Mariia RudykEducational and Scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 2, Hlushkova Avenue, Kyiv, 03022, Ukraine. rudyk_marie@knu.ua.
Alexandr BalakinPhysical Chemistry, Vector Vitale, North Miami Beach, USA.
Sergey GurinPhysical Chemistry, Vector Vitale, North Miami Beach, USA.
Taisa DovbynchukEducational and Scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 2, Hlushkova Avenue, Kyiv, 03022, Ukraine.
Roman ByshovetsDepartment of Internal Diseases, Bogomolets National Medical University, 13, Shevchenko Blvd., Kyiv, 01004, Ukraine.
Nataliia DzubenkoEducational and Scientific Institute of High Technologies, Taras Shevchenko National University of Kyiv, 4g, Hlushkova Avenue, Kyiv, 03022, Ukraine.
Ganna TolstanovaEducational and Scientific Institute of High Technologies, Taras Shevchenko National University of Kyiv, 4g, Hlushkova Avenue, Kyiv, 03022, Ukraine.
Larysa SkivkaEducational and Scientific Centre "Institute of Biology and Medicine", Taras Shevchenko National University of Kyiv, 2, Hlushkova Avenue, Kyiv, 03022, Ukraine.

Funding

Taras Shevchenko National University of Kyiv N 19DP036-03
6 · The paper itself

Abstract

Alzheimer disease (AD) is a debilitating progressive dementia, whose pathophysiology is not fully understood. Chronic inflammation is now widely accepted as one of the key features of AD pathogenesis. Because of this, anti-inflammatory preparations are considered as putative disease modifying agents. A new compound of zinc aspartate with enriched light atoms

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesAnti-Inflammatory AgentsAspartic AcidCognitionPeptide FragmentsZincAnimalsDisease Models, AnimalHippocampusInflammationMaleMicrogliaRatsAmyloid beta-Peptidesamyloid beta-protein (1-40)Anti-Inflammatory AgentsAspartic AcidPeptide FragmentsZincAlzheimer diseaseAnti-inflammatory agentCognitive improvementInflammationNeuroinflammationStable light isotope enriched zinc aspartate

Identifiers

PMID40274975
PMCPMC12022080

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.